Last updated: May 1, 2026, 5:07 am
PSTU-01 - 31 - Beyond the gene: Integrating pharmacogenomics into digital care pathways
Tracks
Track 2
| Tuesday, September 1, 2026 |
| 11:00 AM - 12:30 PM |
Details
Organised by the FIP Technology Advisory Group in collaboration with the FIP Hospital Pharmacy Section
Chair(s)
Prof. Heba Mohamed, Member, FIP Technology Advisory Group, Egypt & Dr Shania Liu, Chair of FIP’s Hospital Pharmacy Section Research Committee and member of Communications and Digital Committee, Australia
Introduction:
Pharmacogenomics (PGx) is redefining how medications are prescribed, dispensed and monitored, ushering in an era of truly personalised medicine. However, its clinical and system-level impact depends on how effectively genomics insights are embedded within integrated digital care pathways that support continuity of care, equity, and sustainable health system transformation.
This joint Technology Advisory Group-Hospital Pharmacy session along with the Personalised and Precision Medicine SIG demonstrates how pharmacists can translate pharmacogenomic data into actionable, technology-enabled clinical decisions.
In addition, the session will critically acknowledge current limitations in pharmacogenomics adoption, including variability in the strength of evidence, workforce readiness, data interoperability, cost, infrastructure constraints at low- and middle-income countries and resource-variable healthcare settings.
To enhance applicability and scalability, the session will introduce practical implementation frameworks aligned with existing FIP digital health and precision medicine initiatives.
Programme:
Learning objectives:
1. Understand the foundations, benefits, and clinical value of pharmacogenomics and how digital systems enable its translation into personalised patient care.
2. Demonstrate how pharmacogenomic data can be integrated into digital health systems for real-time effective and optimised therapeutic decision-making.
3. Explore strategies for scaling digital pharmacogenomics through collaboration, workforce development, and system integration.
Take home messages:
Digital pharmacogenomics bridges genetics and care. Integration of AI-based decision support into the prescribing process within pharmacies could enable pharmacists to provide safer, more individualised treatment. Integrating genomic data with digital workflows improves accuracy, enhances patient engagement, and strengthens clinical governance, empowering pharmacists to lead the transformation toward precision, equitable health care.
FIP Development Goals:
To learn more about these FIP Development Goals, click on the links below.
FIP Development Goal 7: Advancing Integrated Services
FIP Development Goal 19: Patient Safety
FIP Development Goal 20: Digital Health
| 11:00 – 11:10 | Introduction by the chairs |
| 11:10 – 11:30 | From concept to care: Pharmacogenomics in the digital ERA |
| Dr. Osma Elhassan, Dubai Health Authority, UAE | |
| 11:30 – 11:50 | Digital pharmacogenomics in practice across the care continuum: Real-world outcomes and lessons learned |
| Dr. Cyrine Haidar, St. Jude Children’s Research Hospital, USA | |
| 11:50 – 12:05 | Panel discussion with chairs, speakers and additional panellists |
| 12:05 – 12:20 | Q&A |
| 12:20 – 12:30 | Closing remarks by the chairs |
Chairs & speakers
Dr Osma Elhassan
Dubai Health Authority
From concept to care: Pharmacogenomics in the digital ERA
Prof. Heba Mohamed
Professor
Cairo University and member FIP Technology Advisory Group
Chairing of 31 - Beyond the gene: Integrating pharmacogenomics into digital care pathways
Dr Shania Liu
University Of Alberta & University of Sydney
Chairing of 31 - Beyond the gene: Integrating pharmacogenomics into digital care pathways
Dr Cyrine Haidar
St. Jude Children’s Research Hospital
Digital pharmacogenomics in practice across the care continuum: Real-world outcomes and lessons learned
